Literature DB >> 8527231

Apolipoprotein E and the apolipoprotein E-deficient mouse.

A S Plump1, J L Breslow.   

Abstract

Apolipoprotein E (apoE) is one of several lipoprotein transfer genes. A primary function of this protein is the mediation of receptor-mediated lipoprotein removal from the blood. Several studies have demonstrated that genetic variation at the apoE locus is associated with an increased risk of developing atherosclerosis, and recent studies implicate this same genetic variation in determining susceptibility to Alzheimer's disease. An apoE-deficient mouse has been created to further understand the role of apoE in these areas. This review briefly discussed the biological and clinical importance of this protein and describes the early experiments performed in the apoE-deficient mouse.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527231     DOI: 10.1146/annurev.nu.15.070195.002431

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  47 in total

1.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.

Authors:  Ling Li; Wei Weng; Earl H Harrison; Edward A Fisher
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

3.  Quantifying cholesterol synthesis in vivo using (2)H(2)O: enabling back-to-back studies in the same subject.

Authors:  Stephen F Previs; Ablatt Mahsut; Alison Kulick; Keiana Dunn; Genevieve Andrews-Kelly; Christopher Johnson; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sheng-Ping Wang; Karim Azer; Jing Xu; Douglas G Johns; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-04-17       Impact factor: 5.922

Review 4.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 5.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

6.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Authors:  Ts Jeong; S L Schissel; I Tabas; H J Pownall; A R Tall; X Jiang
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

7.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.

Authors:  David J Kennedy; Sai D Kuchibhotla; Ella Guy; Young Mi Park; George Nimako; DiFernando Vanegas; Richard E Morton; Maria Febbraio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

Review 9.  The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Mol Neurobiol       Date:  2010-01-07       Impact factor: 5.590

10.  Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.

Authors:  Jing Liu; Hongqi Zhang; Zhiqiang Li; Tiruneh K Hailemariam; Mahua Chakraborty; Kailiu Jiang; Daniel Qiu; Hai H Bui; David A Peake; Ming-Shang Kuo; Raj Wadgaonkar; Guoqing Cao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.